
|Articles|February 1, 2002
Disease debut
San Francisco - Dermatopathologists from two U.S. universities and clinicians at a California renal transplant hospital have brought a new skin disease to the attention of the Centers for Disease Control and Prevention (CDC).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
5














